Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Hillman Solutions
HLMN
$1.55B
| $137K | ﹤0.01% |
18,988
-18,992
| -50% | -$143K |
|
2277
Frontier Group Holdings
ULCC
$1.61B
| $137K | ﹤0.01% |
13,336
-13,336
| -50% | -$155K |
|
2278
Joby Aviation
JOBY
$7.12B
| $134K | ﹤0.01% |
+40,046
| New | +$162K |
|
|
CTIC
2279
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $134K | ﹤0.01% |
+22,277
| New | +$122K |
|
2280
Pitney Bowes
PBI
$2.46B
| $133K | ﹤0.01% |
35,122
-35,128
| -50% | -$118K |
|
|
TELL
2281
DELISTED
Tellurian Inc.
TELL
| $132K | ﹤0.01% |
79,074
-79,062
| -50% | -$198K |
|
|
RTL
2282
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $132K | ﹤0.01% |
22,261
-22,261
| -50% | -$142K |
|
2283
Coursera
COUR
$1.51B
| $131K | ﹤0.01% |
11,030
-11,034
| -50% | -$139K |
|
2284
Yext
YEXT
$552M
| $130K | ﹤0.01% |
19,952
-19,952
| -50% | -$109K |
|
2285
Amplitude
AMPL
$1.14B
| $126K | ﹤0.01% |
10,466
-10,466
| -50% | -$148K |
|
2286
Rocket Lab Corp
RKLB
$40.4B
| $126K | ﹤0.01% |
33,292
-33,294
| -50% | -$145K |
|
2287
Anavex Life Sciences
AVXL
$250M
| $126K | ﹤0.01% |
13,570
-13,570
| -50% | -$145K |
|
|
LGF.B
2288
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $125K | ﹤0.01% |
23,097
-23,097
| -50% | -$153K |
|
|
MTTR
2289
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $125K | ﹤0.01% |
44,563
-44,573
| -50% | -$143K |
|
2290
WisdomTree
WT
$2.88B
| $125K | ﹤0.01% |
22,910
-22,914
| -50% | -$119K |
|
2291
W&T Offshore
WTI
$515M
| $125K | ﹤0.01% |
22,373
-22,373
| -50% | -$154K |
|
2292
Cerus
CERS
$579M
| $125K | ﹤0.01% |
34,192
-34,200
| -50% | -$129K |
|
2293
Compass
COMP
$8.56B
| $124K | ﹤0.01% |
53,391
-53,391
| -50% | -$140K |
|
2294
Theravance Biopharma
TBPH
$873M
| $123K | ﹤0.01% |
10,988
-10,990
| -50% | -$116K |
|
2295
Designer Brands
DBI
$314M
| $122K | ﹤0.01% |
12,446
-12,446
| -50% | -$168K |
|
2296
Editas Medicine
EDIT
$413M
| $121K | ﹤0.01% |
13,691
-13,691
| -50% | -$150K |
|
2297
Perella Weinberg Partners
PWP
$1.09B
| $121K | ﹤0.01% |
+12,354
| New | +$106K |
|
2298
OneSpaWorld
OSW
$2.64B
| $121K | ﹤0.01% |
12,976
-12,976
| -50% | -$123K |
|
|
SCS
2299
DELISTED
Steelcase
SCS
| $121K | ﹤0.01% |
17,083
-17,083
| -50% | -$126K |
|
2300
American Well
AMWL
$181M
| $120K | ﹤0.01% |
2,119
-2,119
| -50% | -$153K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.